Tower Research Capital (TRC)’s Cymabay Therapeutics CBAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,517
Closed -$248K 6266
2023
Q4
$248K Buy
10,517
+8,636
+459% +$204K ﹤0.01% 1918
2023
Q3
$28K Sell
1,881
-23,998
-93% -$358K ﹤0.01% 3073
2023
Q2
$283K Buy
25,879
+24,051
+1,316% +$263K 0.01% 1321
2023
Q1
$16K Sell
1,828
-229
-11% -$2K ﹤0.01% 3750
2022
Q4
$13K Sell
2,057
-4,470
-68% -$28.3K ﹤0.01% 3656
2022
Q3
$23K Sell
6,527
-5,859
-47% -$20.6K ﹤0.01% 3837
2022
Q2
$36K Sell
12,386
-13,996
-53% -$40.7K ﹤0.01% 3200
2022
Q1
$82K Buy
26,382
+21,789
+474% +$67.7K ﹤0.01% 2365
2021
Q4
$16K Sell
4,593
-8,052
-64% -$28.1K ﹤0.01% 3951
2021
Q3
$46K Sell
12,645
-6,830
-35% -$24.8K ﹤0.01% 3036
2021
Q2
$85K Buy
19,475
+13,016
+202% +$56.8K ﹤0.01% 2562
2021
Q1
$29K Sell
6,459
-10,227
-61% -$45.9K ﹤0.01% 3592
2020
Q4
$95K Sell
16,686
-58,523
-78% -$333K ﹤0.01% 2401
2020
Q3
$545K Buy
75,209
+60,354
+406% +$437K 0.01% 1589
2020
Q2
$52K Buy
14,855
+9,327
+169% +$32.6K ﹤0.01% 3018
2020
Q1
$8K Buy
+5,528
New +$8K ﹤0.01% 2142
2019
Q4
Sell
-11,950
Closed -$61K 4571
2019
Q3
$61K Buy
+11,950
New +$61K ﹤0.01% 1664
2018
Q4
Sell
-3,132
Closed -$35K 4500
2018
Q3
$35K Buy
+3,132
New +$35K ﹤0.01% 1990
2018
Q2
Sell
-5,384
Closed -$70K 4169
2018
Q1
$70K Buy
5,384
+2,713
+102% +$35.3K 0.01% 1495
2017
Q4
$25K Sell
2,671
-2,227
-45% -$20.8K ﹤0.01% 1902
2017
Q3
$39K Buy
+4,898
New +$39K ﹤0.01% 2213
2016
Q4
Sell
-387
Closed -$1K 4532
2016
Q3
$1K Buy
+387
New +$1K ﹤0.01% 3406
2016
Q2
Sell
-5,777
Closed -$8K 5118
2016
Q1
$8K Buy
5,777
+3,304
+134% +$4.58K ﹤0.01% 2259
2015
Q4
$4K Buy
+2,473
New +$4K ﹤0.01% 3281